Biotech Startups

AMSlab is a biotechnology company focused on research, development, and innovation in analytical methods and quality control. The company develops solutions for detecting and identifying compounds across healthcare, food safety, marine toxins, and related biotech applications.

1 investor

AMSilk produces biotech-derived silk protein yarns for textile applications including fashion, accessories, and automotive interiors, using fermentation-based bioprocessing instead of traditional sericulture. The company's fibers are designed to match or exceed conventional silk performance while reducing water consumption, land use, and carbon emissions.

1 investor

Amygdala Neurosciences is a biopharmaceutical company developing oral medications to treat alcohol and substance use disorders by targeting the ALDH2 enzyme. The company addresses unmet clinical needs in addiction treatment through novel pharmacotherapies.

1 investor

A drug discovery company focused on medicinal chemistry and preclinical research across multiple therapeutic areas.

1 investor

Everlife Analisa Resources is a laboratory and scientific solutions distributor founded in 1999, providing instruments, chemistries, consumables, software, and technical services to life sciences, analytical testing, and diagnostic markets across Asia. The company serves scientists, research institutions, biotechnology firms, and industries including pharmaceuticals, food, and chemicals.

1 investor

AnalytiChem manufactures and distributes laboratory chemicals and reference materials, including certified reference materials, elemental and organic standards, prepared culture media, high-purity acids, and instrument consumables. It serves scientists and laboratories across the mining, petroleum, environmental, food, and life sciences industries.

1 investor

AnalytiCon Discovery specializes in natural product research and development, providing natural compound libraries and collections along with discovery and development technologies. It serves the pharmaceutical, cosmetic, and nutritional product industries.

1 investor

Anatomiz3D develops patient-specific surgical planning solutions and tissue engineering products using 3D printing and bioprinting technologies for the healthcare industry. The company aims to improve surgical outcomes and eventually reduce organ transplant dependency through customized medical interventions.

1 investor

Anaula builds autonomous bioreactors for pharmaceutical and biological production, integrating hardware, robotics, and software into a closed-loop system that senses, controls, and corrects itself to reduce operator-caused batch failures. The company targets biological manufacturing facilities.

1 investor

Anavex Life Sciences is a clinical-stage biopharmaceutical company developing oral therapeutics for central nervous system disorders, including Alzheimer's disease, Rett syndrome, and Fragile X syndrome. Its lead compound is ANAVEX 2-73 (blarcamesine), targeting early Alzheimer's and neurodevelopmental rare diseases.

1 investor

Anavo Therapeutics is a biopharmaceutical company using its IGNITE platform to develop phosphatase-targeted allosteric modulators, addressing drug targets previously considered undruggable. It is building a proprietary pipeline of therapeutic programs targeting autoimmune diseases and cancer, with headquarters in Leiden, Netherlands and an R&D hub in Heidelberg, Germany.

1 investor

Andon Bio is a spinout from the University of Colorado School of Medicine developing aa-tRNA-seq, a molecular biology method for studying protein translation and tRNA aminoacylation. The company builds experimental and computational tools for research into cellular translation mechanisms.

1 investor

Andon Bio measures a cell's internal supply chain in real time as proteins are being produced, linking a protein sequence's resource demands to how well it will express. The company aims to help researchers predict protein manufacturability and choose which designed sequences to build, serving protein design and bioproduction workflows.

1 investor

AndzonBio operates a suite of thematic "pipeline builder" studios that accelerate the industrial development of academic life sciences projects into biotech companies, focusing on specific therapeutic areas such as cardiovascular/renal/metabolic disorders and neurological disorders. Launched by AdBio Partners and Inserm Transfert, it provides expert support, R&D budgets, and validation to turn academic programs into viable therapeutics companies.

1 investor

Andzonbio1 is a biotech start-up developing therapeutics and building a pipeline, supported by public and private funding sources in France. The company is backed by Inserm Transfert and AdBio partners, both focused on life sciences innovation and early-stage therapeutic investments.

1 investor

AndzonBio2 develops neuroinflammation therapies targeting STING and lipid peroxidation pathways, aiming to intervene in central nervous system diseases through translational research and drug development.

1 investor

Anebulo Pharmaceuticals is developing selonabant, a drug candidate intended to reverse cannabis-induced toxicities, including acute CNS depression in children and acute cannabinoid intoxication in adults. The company is a clinical-stage pharmaceutical developer targeting conditions for which there are no approved treatments.

1 investor

Anesiva is a biopharmaceutical company developing Nexletol for diet management.

1 investor

Angarus Therapeutics was a biotechnology company. It is no longer operating.

1 investor

Angel City Bio is a physician-scientist founded pharmaceutical company developing bile-acid-based treatments for gastrointestinal diseases, with programs targeting indications such as GLP-1-associated gallbladder disease and Crohn's disease. Its approach uses enterohepatic recirculation biology and 505(b)(2) regulatory pathways to pursue multiple drug targets.

1 investor

Angelini Pharma is an international pharmaceutical company that researches, develops, and commercializes treatments focused on Brain Health (including Mental Health and Epilepsy), Specialty and Primary Care, and Consumer Healthcare. It markets branded prescription and consumer health products across Europe and the United States.

1 investor

AngenMed develops neoantigen-targeting cell-based cancer immunotherapies, including dendritic cell vaccines and neoantigen-specific T cell products personalized to each patient's tumor mutations. The company operates in the biotech and cancer therapeutics space, using tumor sequencing to identify neoantigens and manufacture DC and T-cell products.

1 investor

Angiocrine Bioscience is a biotechnology company focused on developing therapies, presenting its work under a science-driven mission to cure disease.

1 investor

Anju Software provides data management and integration solutions for pharmaceutical companies, clinical research organizations, and medical device companies. The company specializes in life science information management systems that enable data flow and third-party system connectivity.

1 investor